Development and external validation of a nomogram to predict the risk of Upper gastrointestinal precancerous lesions in a non-high-incidence area
- PMID: 32937009
- PMCID: PMC7666758
- DOI: 10.1002/cam4.3462
Development and external validation of a nomogram to predict the risk of Upper gastrointestinal precancerous lesions in a non-high-incidence area
Abstract
Background: Upper gastrointestinal precancerous lesions (UGPL) is the major preventable disease in non-high-incidence area. A prognostic nomogram was constructed to predict and identity susceptible population of UGPL before endoscope screening.
Methods: We recruited 300 ,016 eligible participants for upper gastrointestinal cancer (UGC) screening aged 40-74 years from two cities in Hunan province from 2012 to 2019. Individuals at high risk of UGC on basis of questionnaire estimation underwent endoscopic screening. Participants in two cities accepting endoscopy were used as training and external validation cohorts, respectively. A nomogram was developed based on independent prognostic factors of UGPL determined in multivariable logistic regression analysis.
Results: Of 35, 621 with high risk for UGC, 10, 364 subjects undertook endoscopy (participation rate of 29.1%). The detection rate for UGPL was 4.55%. The nomogram showed that age, gender, mental trama, picked food, and atrophic gastritis history in a descending order were significant contributors to UGPL risk. The C-index value of internal and external validation of the model is 0.612 and 0.670, respectively. The calibration data for UGPL showed optimal agreement between the nomogram prediction and actual observation. Furthermore, high-risk and low-risk group divided based on score from the nomogram predicted a significantly distinct detection rate.
Conclusion: The nomogram provides screening workers a simple and accurate tool for identifying individuals at a higher risk of UGPL as primary screening before endoscopy among Chinese population in non-high-risk areas, thus reducing the incidence of UGC by improving the UGPL detection.
Keywords: endoscopy screening; external validation; nomogram; non-high-incidence area; upper gastrointestinal precancerous lesions.
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Community-Based Upper Gastrointestinal Cancer Screening in a Randomized Controlled Trial: Baseline Results in a Non-high-incidence Area.Cancer Prev Res (Phila). 2020 Mar;13(3):317-328. doi: 10.1158/1940-6207.CAPR-19-0422. Epub 2019 Dec 23. Cancer Prev Res (Phila). 2020. PMID: 31871223 Clinical Trial.
-
Outcomes of upper gastrointestinal cancer screening in high-risk individuals: a population-based prospective study in Northeast China.BMJ Open. 2022 Feb 15;12(2):e046134. doi: 10.1136/bmjopen-2020-046134. BMJ Open. 2022. PMID: 35168959 Free PMC article.
-
Development of a prognostic nomogram for cirrhotic patients with upper gastrointestinal bleeding.Eur J Gastroenterol Hepatol. 2017 Oct;29(10):1166-1173. doi: 10.1097/MEG.0000000000000943. Eur J Gastroenterol Hepatol. 2017. PMID: 28746121
-
The role of endoscopy in the surveillance of premalignant conditions of the upper gastrointestinal tract. American Society for Gastrointestinal Endoscopy.Gastrointest Endosc. 1998 Dec;48(6):663-8. doi: 10.1016/s0016-5107(98)70055-0. Gastrointest Endosc. 1998. PMID: 9852468 Review. No abstract available.
-
Deep learning for diagnosis of precancerous lesions in upper gastrointestinal endoscopy: A review.World J Gastroenterol. 2021 May 28;27(20):2531-2544. doi: 10.3748/wjg.v27.i20.2531. World J Gastroenterol. 2021. PMID: 34092974 Free PMC article. Review.
Cited by
-
Development and validation of a nomogram for obesity and related factors to detect gastric precancerous lesions in the Chinese population: a retrospective cohort study.Front Oncol. 2024 Nov 20;14:1419845. doi: 10.3389/fonc.2024.1419845. eCollection 2024. Front Oncol. 2024. PMID: 39634264 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394‐424. - PubMed
-
- Sun KX, Zheng RS, Zhang SW, et al. Report of cancer incidence and mortality in different areas of China, 2015. China Cancer. 2019;28:1‐11.
-
- Zeng H, Chen W, Chen J, et al. Changing cancer survival in China during 2003–15: a pooled analysis of 17 population‐based cancer registries. The Lancet Global Health. 2018;6:e555‐e567. - PubMed
-
- Qiao Y. An important milestone in the epidemiological study of esophageal cancer. Chin J Clin Oncol. 2016;12:500‐501.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources